L6 - Global Health Governance + WTO Flashcards

1
Q

What is equity in global health governance?

A

Equity = Absence of remediable inequities.

Inequity: Inequality + remediable + reasonable effort + fair process (national level).

Global Level Challenges:
Is inequity remediable?
What constitutes reasonable efforts?
What defines a fair process?

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Right to health?

A

Right to Health: Obligation of governments to provide healthcare. Emergent human right, not fully crystallised (especially internationally).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Think about a human rights perspective on health. Are there traces of this in international
human rights law and other international agreements?

A

Western States - Favoured ICCPR: Focus on freedom (negative rights). (Example: Protection from interference, civil/political rights)

Communist States - Favoured ICESCR: Focus on entitlements (positive rights). (Example: Access to healthcare, economic/social rights)

Key Distinction: Freedoms (Negative Rights): Freedom from government interference ≈ civil and political rights.

Rights/Entitlements (Positive Rights): Obligation for government to provide services ≈ economic, social, and cultural rights.
International Law:

ICCPR and ICESCR reflect competing priorities of “freedoms” vs. “entitlements.”
Human rights to health primarily addressed under ICESCR Article 12 (right to the highest attainable standard of health).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

How was health addressed in the MDGs, and how now in the SDGs?

A

Health in MDGs vs. SDGs:

MDGs (2000–2015):

Focused on three specific health targets:
Child Mortality (Goal 4)
Maternal Health (Goal 5)
Combat Infectious Diseases (Goal 6, e.g., HIV/AIDS, malaria).

SDGs (2015–2030):
Broader approach to health under SDG 3: Good Health and Well-being.
Retained the three MDG targets (child mortality, maternal health, infectious diseases).

Expanded scope to include:
Target 3.8: Achieve universal health coverage (UHC).
Target 3.a: Strengthen tobacco control.
Target 3.d: Enhance global capacity for early warning, risk reduction, and health risk management (ties to global health security).

Leadership Influence:
WHO Director-General Tedros Adhanom emphasizes Universal Health Coverage (UHC) as a cornerstone of global health under the SDGs.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Discuss critically the concept of and policies concerning global health security.

A

Focus: Prevent/manage global health threats (e.g., pandemics, IHR).

Criticism:
Prioritises high-income countries; neglects systemic health issues in poorer nations.

Relies on vertical (disease-specific) approaches, weakening national health systems.

Benefit: Saves lives by controlling outbreaks.

Solution: Horizontal approaches (health system strengthening) address root causes and prepare for both specific and general health challenges.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What is universal health coverage?

A

Ensures access to essential, quality health services (promotion, prevention, treatment, rehab, palliative care) without financial hardship.

Aims to address major causes of disease and death with adequate service quality.

Challenges:
4.5 billion lack primary health services (e.g., newborn care, response capacity).

Half of the global population lacks access to social security.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

You should understand the essence of the WHO’s International Health Regulations, and the notion of PHEIC within them.

A

IHR (est. 1969, revised 2005):

Legally binding treaty to coordinate epidemic prevention, preparedness, and response.

Key elements:
- Surveillance capacity to detect outbreaks.
- Mandatory notification of potential PHEICs.
- National response capacities required.
- WHO disseminates info to member states.

PHEIC (Public Health Emergency of International Concern):

  • Declared by WHO Director-General with Emergency Committee advice.
  • Indicates exceptional global health risks needing coordinated action.
  • Leads to non-binding WHO recommendations (e.g., travel advisories, containment).
    Examples: COVID-19, 2014 Ebola outbreak.

Purpose of IHR: Enhance global public health security by improving preparedness, communication, and collaboration to prevent and respond to international disease outbreaks.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Which fundamental policy changes have been visible in global health governance over time? Why was the 1978 Alma-Ata conference important? And subsequently the neoliberal turn?

A

Alma-Ata Declaration (1978):

Goal: “Health for All by 2000.” Declared health a fundamental human right.

  • Advocated horizontal approaches (health system strengthening).
  • Linked health to social, economic reform (NIEO context).
  • Emphasised state responsibility for public health.

1980s Neoliberal Turn:
- Alma-Ata deemed too broad, costly, and socialist.
-Shift to Selective Primary Health Care (disease specific focus).
- IMF/World Bank reforms: budget cuts, privatisation, user fees.
- Focus on vertical approaches and global health security.
- Weakened national health systems.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Recent changes to the IHR

A

Definition of Pandemic Emergency: Defined as a form of PHEIC with no specified consequences.

WHO Coordination: Better coordination during PHEIC to ensure timely, equitable access to health products, but no legal power for equity.

Financial Mechanism: Vague provisions for developing countries; no committed funds. Rich countries resisted a WHO Fund.

Essence: WHO gains more authority in coordinating health emergencies.

Criticism:
No robust review mechanism or enforcement (no compliance “police”).

Lack of detail on preparedness requirements (e.g., PPE).

No strong, legally binding commitments on equity and finance.

Global South Criticism: Demands equitable access to health products and better terms in research & development agreements.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Global health justice?

A

Global Health Justice: Access to health and addressing remediable inequalities (e.g., maternal/child health).

Key Comparison: Health Security: Vaccines, emergency preparedness.

Health Justice: Broader access, equity in health systems.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Horizontal and
vertical approaches? (health)

A

Vertical: Disease-specific focus (e.g., targeting one illness).

Horizontal: Strengthening entire health systems (e.g., preventive care, broader readiness).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Global health security?

A

Focus: Infectious diseases with global spread (e.g., MDG 6: Combat HIV/AIDS, malaria).
Narrower concept than the right to health.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Evaluate the WHO’s performance during Covid-19. Was it impactful? Explain.

A
  • IHR + WHO were marginalised as countries chose to pursue their own policies - national sovereignty prevailed
  1. closing borders (against historical WHO preference)
  2. export restrictions for medical supplies
  3. vaccine nationalism

WHO weaknesses
- no real powers, underfunded, reduced to ‘meta governance’ role, IHR suffered from mock compliance, many countries had been hollowed out from NL

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

How was the WHO affected by great power politics?

A
  • relationship with china
  • 29 May 2020: Trump leaves WHO - 1/6 of budget gone (undone by Biden)
  • challenges of navigating between powers
  • 80% of funding from MS and philanthropists
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

You should be aware about the issues of supply of pandemic-related health products
(protectives, diagnostics, therapeutics, vaccines).

A
  • Opposition from EU, UK, on vaccines ‘IP’
  • US support of waiver for vaccines, but opposed to waiver for medicines

June 2022 compromise:
- waiver only applied to vaccines, only for developing countries, countries using compulsory licensing can export but the latter cannot re-export
- Critics disappointed: it took too long, it’s not for all pandemic-related products, not for all countries

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Discuss the Covax initiative.

A

COVAX is the vaccine pilar of the…

… Access to COVID-19 Tools (ACT) Accelerator: a framework for collaboration on pandemic-related products

Initiative of WHO, UNICEF, GAVI, EU among others

Covid vaccines as a “global public good”

Supporting R&D and production in partner companies; agree to purchase from those companies; distribution of vaccines to lower-income countries (“2 billion by the end of 2021”)

But market-based (no compulsory licensing, just paying to the pharmaceutical companies) = expensive

Critics: too slow.

Covax suffered from vaccine nationalism: rich countries first purchased available vaccines

17
Q

Understand the essence of the (draft) pandemic agreement.

A

International instrument for pandemic prevention, preparedness and response
EU initiative

Negotiations started late 2021

To be signed by May 2024 at the World Health Assembly of the WHO – due to failure, term extended by 1 year

Agreement should be legally binding

Draft text Sept 2024: “The WHO Pandemic Agreement” (drafted under leadership of South African and Dutch co-chairs)

Substantial Articles:
General statements on pandemic prevention, surveillance, preparedness (cf. IHR)

Unlike IHR:
One Health Approach
Insistence on resilient health systems
Equity dimension
Commitment to geographically diversified local production (absent in IHR)

Technology transfer

Absent in IHR
Of course, a major battleground
Much reference to ‘encouraging’ and ‘voluntary’ technological transfer.
Reference to existing TRIPS flexibilities (Trade-Related Aspects of Intellectual Property Right)
BUT no consensus on opening up compulsory licensing or coercive measures

18
Q

Why do we need a pandemic agreement while the IHR are already there?

A
  • Real value-added compared to ‘technical IHR’, as it tries to fill governance gaps
  • Tough negotiations, countries insist on sovereignty, voluntariness, protections of TRIPS (Trade-Related Aspects of Intellectual Property Right ) (interests of pharmaceutical companies)
  • Original draft seriously watered down, on a lot of language no agreement yet.

Relationship pandemic agreement & IHR:
-Considered to be complementary, refer to each other, pandemic agreement wants to be consistent with IHR
- Both are WHO legal instruments
- Update IHR is adopted (May 2024), negotiations on pandemic agreement (PA) still underway. Processes have run in parallel.
- IHR is rather technical, focuses on what to do in case of PHEIC
- PA is more political, sets principles, addresses number of essential areas not or poorly covered by IHR
- Both are complementary, PA often vows consistency with IHR.
- Equity dimension Commitment to geographically diversified local production (absent in IHR

Technology transfer: Absent in IHR, of course, a major battleground, Much reference to ‘encouraging’ and ‘voluntary’ technological transfer.Reference to existing TRIPS flexibilities
BUT no consensus on opening up compulsory licensing or coercive measures

19
Q

What is the discussion on pathogen access and benefit sharing basically about?

A

Pathogen access & benefit-sharing system

  • Absent in IHR, here PA can have real value added. But very difficult domain, politically and technically
  • To be settled by COP

Challenge:
- Countries of origin must immediately share what they have
- But they should also enjoy part of the benefits from ‘their biological resources’

20
Q

What is the discussion on supply chain and logistics in the context of pandemics basically about?

A
  • Absent in IHR. About cooperation and solidarity. Vital to have stocks, remove barriers, export restrictions, avoid harmful hoarding, vaccine nationalism, etc.
  • Seeming promises to do better
    A Global Supply Chain and Logistics (GSCL) Network will be set-up, coordinated by WHO
    Operationalisation is still very challenging

Funding
- Nothing in place yet (I think) They seem to look for Coordinating Financial Mechanism, merging with funding mechanism for IHR
[World Bank already has its Pandemic Fund (created in 2022 at the instigation of the G20)]

FOLLOW-UP
- A Conference of the Parties (COP) will be set up
For periodic monitoring of implementation of the PA
- PA does not provide for monitoring and review mechanism, [first] COP meeting will have to design it
- No guarantee at all for robust monitoring mechanism